Auxotrophic strains of staphylococcus bacterium
AssigneeAzitra Inc
InventorRichard Andrews
Life of this patent
Estimating the term…
Abstract
The present disclosure provides recombinant Staphylococcus bacterium (e.g. S. epidermidis) that are dependent on D-alanine for growth. In one aspect, the disclosure features a recombinant Staphylococcus bacterium comprising two inactivated alanine racemase genes (Δalr1Δalr2); and an inactivated D-alanine aminotransferase (dat) gene. In another aspect, the disclosure features a method of making the recombinant Staphylococcus bacterium. In another aspect, the disclosure features a method of treating or preventing a rash in a subject, comprising administering to the subject a population of the recombinant Staphylococcus bacterium of any one of the aspects or embodiments described herein, in an effective amount to treat or prevent the rash in the subject.
Claims16
A recombinant Staphylococcus bacterium comprising:
- two inactivated alanine racemase genes (Δalr1Δalr2);
- and
- an inactivated D-alanine aminotransferase (dat) gene.
A method of making a recombinant Staphylococcus bacterium comprising:
- (i) transforming a plasmid comprising D-alanine aminotransferase (dat) knockout into competent cells of Staphylococcus strain (SEΔalr1Δalr2);
- (ii) detecting the presence of the knockout plasmid in transformed cells;
- (iii) incubating the transformed cells identified in step (ii);
- and
- (iv) purifying isolated colonies.
Dependencies are inferred from the claim text.